UTI vs LINC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

UTI

46.2
AI Score
VS
LINC Wins

LINC

30.8
AI Score

Investment Advisor Scores

UTI

46score
Recommendation
HOLD

LINC

31score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI LINC Winner
Forward P/E 27.248 26.0417 LINC
PEG Ratio 1.8142 1.7369 LINC
Revenue Growth 7.2% 22.4% LINC
Earnings Growth -78.9% 20.0% LINC
Tradestie Score 46.2/100 30.8/100 UTI
Profit Margin 3.9% 4.0% LINC
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY UTI

Relative Price Performance (Last 90 Days)

UTI 1M: +6.1% · 3M: -42.7% LINC 1M: -8.8% · 3M: -45.8%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $21.66

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.5%), weak momentum, RSI 38

RSI (14): 37.6 · Price: $21.96

Fundamentals Snapshot

Metric UTI LINC
Market Cap — —
Forward P/E 29.5 21.0
Trailing P/E 34.1 29.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.61 0.73
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LINC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.